In summary, our data present a novel methodology for the controlled delivery of hepatic FGF21 expression in mice and demonstrate the successful implementation of this strategy to reduce the effects of diet-induced obesity in female C57BL6/J mice. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.